The safety and efficacy of human umbilical cord mesenchymal stem cell for acute respiratory distress syndrome: an open-label and multicenter phase 1 clinical trial - Quiz - MDSpire

The safety and efficacy of human umbilical cord mesenchymal stem cell for acute respiratory distress syndrome: an open-label and multicenter phase 1 clinical trial

  • By

  • Qinggang Ge

  • Libo Zheng

  • Man Zhao

  • Chao Li

  • Zhiling Zhao

  • Zongyu Wang

  • Qiang Zhang

  • Mai Shi

  • Yuxuan Li

  • Jianan Zhang

  • Yixian Qiao

  • Senhao Wei

  • Ning Shen

  • Haomiao Long

  • Yongjun Liu

  • Jie Qiao

  • June 10, 2026

  • 0 min

Share

Original Source(s)

The safety and efficacy of human umbilical cord mesenchymal stem cell for acute respiratory distress syndrome: an open-label and multicenter phase 1 clinical trial

  • by Qinggang Ge, Libo Zheng, Man Zhao, Chao Li, Zhiling Zhao, Zongyu Wang, Qiang Zhang, Mai Shi, Yuxuan Li, Jianan Zhang, Yixian Qiao, Senhao Wei, Ning Shen, Haomiao Long, Yongjun Liu, Jie Qiao

  • June 10, 2026

Related Content

Detection of drug-induced acute respiratory distress syndrome risk signals in FAERS: a real-world pharmacovigilance study

Type I interferon pathway activation in connective tissue disease associated interstitial lung disease

Association of advanced therapies for intermediate- to high-risk pulmonary embolism with improved right ventricular function on outpatient follow-up among survivors